cdmo.directory
← Compare landing

Dipharma vs Neuland Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/dipharma/neulandlabs

CategoryDipharmaNeuland Laboratories
Listed sitecdmocdmo
SummaryGlobal CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.Global API CDMO supporting biotechnology and pharmaceutical companies in design, development, and manufacturing of complex active pharmaceutical ingredients from early-stage drug development through commercial scale.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Peptide Manufacturing
Modalities
  • Small Molecule
  • Small Molecule
  • Peptide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
  • R&D Centre, India
  • Unit I - Bonthapally, Bonthapally, India
  • Unit II - Pashamylaram, Pashamylaram, India
  • Unit III - Gaddapotharam, Gaddapotharam, India
  • Upcoming Peptide Facility, India
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.